Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Messa

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Haematologica|August 2, 2007
Nuclear factor kB as a target for new drug development in myeloid malignanciesDaniela Cilloni, Giovanni Martinelli, Francesca Messa, et al.
Blood|March 5, 2004
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patientsDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Myelodysplastic syndromesDaniela Cilloni, Francesca Messa, Sonia Carturan, et al.
Blood|July 2, 2003
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detectionDaniela Cilloni, Enrico Gottardi, Milena Fava, et al.
Pediatric Hematology and Oncology|April 22, 2009
Hypereosinophilic syndrome in childhood: clinical and molecular features of two casesPiero Farruggia, Paolo D'Angelo, Antonio Acquaviva, et al.
The International Journal of Biological Markers|November 19, 2013
A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinomaFrancesca Messa, Federica Tonissi, Enrico Millo, et al.
Blood|September 25, 2003
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemiasDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromesDaniela Cilloni, Emanuela Messa, Francesca Messa, et al.
Haematologica|November 10, 2018
A new BCR-ABL1 <i>Drosophila</i> model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemiaRoberto Bernardoni, Giorgia Giordani, Elisabetta Signorino, et al.
Acta Haematologica|October 1, 2008
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignanciesPaolo Nicoli, Ilaria Defilippi, Sonia Carturan, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Haematologica|August 2, 2007
Nuclear factor kB as a target for new drug development in myeloid malignanciesDaniela Cilloni, Giovanni Martinelli, Francesca Messa, et al.
Blood|March 5, 2004
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patientsDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Myelodysplastic syndromesDaniela Cilloni, Francesca Messa, Sonia Carturan, et al.
Blood|July 2, 2003
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detectionDaniela Cilloni, Enrico Gottardi, Milena Fava, et al.
Pediatric Hematology and Oncology|April 22, 2009
Hypereosinophilic syndrome in childhood: clinical and molecular features of two casesPiero Farruggia, Paolo D'Angelo, Antonio Acquaviva, et al.
The International Journal of Biological Markers|November 19, 2013
A PNA-mediated clamping PCR for routine detection of KRAS mutations in colorectal carcinomaFrancesca Messa, Federica Tonissi, Enrico Millo, et al.
Blood|September 25, 2003
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemiasDaniela Cilloni, Sonia Carturan, Enrico Gottardi, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromesDaniela Cilloni, Emanuela Messa, Francesca Messa, et al.
Haematologica|November 10, 2018
A new BCR-ABL1 <i>Drosophila</i> model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemiaRoberto Bernardoni, Giorgia Giordani, Elisabetta Signorino, et al.
Acta Haematologica|October 1, 2008
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignanciesPaolo Nicoli, Ilaria Defilippi, Sonia Carturan, et al.
Pageof 3